WEDNESDAY, Dec. 10, 2025 (HealthDay News) -- Late effects are rare for patients with sickle cell disease (SCD) undergoing allogeneic hematopoietic cell transpla
ASH: Late Effects Uncommon for Patients With Sickle Cell Disease After Allogeneic HCT
HealthDay1 hrs ago
143


AlterNet
People Human Interest
13 On Your Side
NBC News
Verywell Health
The Conversation
CNN Health
CBS News